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Haemodynamic effects and the visibility
of the surgical field after lidocaine infiltration during
septoplasty under general anaesthesia
Abstract
Background and Purpose: The aim of this study was to determine the
effect of local infiltration of adrenaline- containing lidocaine solution dur-
ing septoplasty under general anaesthesia on systemic haemodynamics and
the visibility of the operative field, and to compare it to the topical applica-
tion of ephedrine.
Patients and Methods: A retrospective, comparative, non-randomised,
open study on 72 ASA physical status I and II patients, aged 20 to 73 years,
scheduled for septoplasty was performed. Lidocaine/adrenaline-ephedrine
group (group LA-E; n=18) received four cotton pledgets soaked with 1 %
ephedrine, and then the submucosal infiltration of 2% lidocaine containing
adrenaline solution (2ml) plus plain 2% lidocaine solution (5ml). Lido-
caine/adrenaline group (LA group; n=25) received the submucosal infil-
tration of 2% lidocaine containing adrenaline solution (2ml) plus plain 2%
lidocaine solution (5ml). Ephedrine group (E group; n=29) received four
cotton pledgets soaked with 1% ephedrine. Heart rate (HR) and mean arte-
rial pressure (MAP) were recorded at predetermined time intervals. Bleed-
ing in the surgical field was rated according to a 6-point scale.
Results: LA and LA-E groups showed significant lower HR and MAP
compared to E-group. LA group showed only slight oscillations in HR. Av-
erage bleeding score was 2.28±0.83 in LA-E, 2.08±0.81 in LA and
3.14±0.74 in E group (p<0.001).
Conclusions: We demonstrated that infiltration of lidocaine with adren-
aline has statistically and clinically better impact on systemic haemodyna-
mics and visibility of the surgical field than that achieved by topical appli-
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LA – E lidocaine/adrenaline with ephedrine
LA – lidocaine/adrenaline
E – ephedrine
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INTRODUCTION
Abloodless and clear surgical field is an everyday chal-lenge during nasal surgery.
Published studies support the combination of lido-
caine, a short acting local anaesthetic, with adrenaline to
be effective in decreasing blood loss and improving visu-
alisation of the surgical field during nasal surgery (1, 2).
In addition, this combination of local anaesthetic infil-
tration, directly in the surgical field, with general anaes-
thesia provides beneficial analgesic effect by blocking no-
ciceptive pathways, and thereby it reduces the need for
systemic analgesics (3).
Ephedrine has a long history of use in otorhinolaryn-
gology as a topical decongestant during nasal examina-
tions (4). Although it is used by some otorhinolaryngolo-
gists as topical pre-treatment for relieving swelling and
bleeding of nasal mucosa during nasal surgery, there is
no clear evidence for its efficacy in nasal surgery under
general anaesthesia.
The aim of this study was to review and evaluate the
current practice of the specific measures used for improv-
ing haemostasis during septoplasty under general anaes-
thesia in our Institution. We wanted to determine the effect
of local infiltration of adrenaline- containing lidocaine
solution compared to the topical application of ephed-




We reviewed data on patients scheduled for different
types of nasal surgery under general anaesthesia in the
Department of Otorhinolaryngology at the General
Hospital »Sveti Duh« in Zagreb, between June 2006 and
February 2009. For the review we used our database that
we fill in on a regular basis with selected vital parameters
following each ear-nose-throat operation.
From the reviewed pool of patients (n=281), we en-
rolled only the patients undergoing septoplasty (n=176).
In addition, we excluded patients with evidence of severe
cardiovascular, renal, haematological, hepatic or respira-
tory disease, and cerebrovascular insufficiency. The final
study sample consisted of 72 adults, 44 men and 28
women, with normal cardiovascular and pulmonary sta-
tus, haematological parameters within the normal range,
and American Society of Anaesthesiologists (ASA) score
I/II. The patients were aged between 20 and 73 years.
The body weight ranged from 53 kg to 110 kg.
Anaesthesia and the applied measures
for the intraoperative control of bleeding
On arrival to the operating theatre, intravenous access
was established by the insertion of an intravenous canul-
la. Anaesthesia was induced with midazolam 2.5–5 mg
(Dormicum®, F. Hoffman-La Roche Ltd., Basel, Swit-
zerland), fentanyl 0.10 mg (Fentanyl®, Janssen Pharma-
ceutica, Beerse, Belgium), propofol 1–2 mg/kg (Diso-
privan®, AstraZeneca, UK Ltd, Macclesfield, Chesire,
United Kingdom). After the use of a facemask for venti-
lation had been checked, the patient was paralysed with
vecuronium 0.1 mg/kg (Norcuron®, N. V. Organon, Oss,
the Netherlands). Two minutes later, another fentanyl
bolus of 0.10 mg was given and trachea was intubated
with a reinforced endotracheal tube of proper size. After
the position of the endotracheal tube had been checked
and secured, a gauze throat pack was inserted. Anaesthe-
sia was maintained with nitrous oxide 60% in oxygen,
and supplemented with additional bolus of midazolam
of 2.5 mg, fentanyl of 0.05 mg or vecuronium 0.001mg/kg
as required. Patients were mechanically ventilated to
keep end-tidal carbon-dioxide tension (PETCO2) to
maintain normocapnia (4.5–5.0 kPa). After induction,
dexamethason 12 mg (Dexamethason Krka®, Krka d.d.,
Novo Mesto, Slovenia) and metoclopramide 10 mg (Re-
glan®, Alkaloid AD – Skopje, Skopje, Macedonia) were
applied intravenously. Doses and time intervals of ap-
plied drugs and the total volume of intravenous fluids
were recorded on the anaesthetic chart. No halogenic in-
halation anaesthetics were used.
During the induction of anaesthesia and the surgery,
patients were monitored using a standard three-lead
electrocardiography, pulse oxymetry, capnometry and
non-invasive arterial pressure monitoring.
After intubation and prior to the surgical incision, pa-
tients received one of three measures for the control of
bleeding in the nasal surgical field. In the first group the
surgeon decongested the nose with four cotton pledgets
soaked with 1% ephedrine (magistral solution made in
the hospital pharmacy), and then applied the submu-
cosal infiltration of 2% lidocaine containing adrenaline
solution (2ml; i.e. 40 mg of lidocaine plus 0.025 mg
adrenaline) (Lidokain-Adrenalin®, Belupo, Croatia) plus
plain 2% lidocaine solution (5mL; i.e. 100 mg of lido-
caine) (Lidokain®, Belupo, Croatia) with 28 gauge-
sized needle (group LA-E; n= 18). In the second group,
the surgeon applied the submucosal infiltration of 2%
lidocaine containing adrenaline solution (2ml; i.e. 40 mg
of lidocaine plus 0.025 mg adrenaline) plus plain 2%
lidocaine solution (5mL; i.e. 100 mg of lidocaine) with
28 gauge- sized needle (group LA; n= 25). In the third
group, the surgeon decongested the nose with four cotton
pledgets soaked with 1% ephedrine (group E; n=29).
The surgeon decided on the patient allocation to one of
these three groups. There were several surgeons and each
one preferred a different solution. Ten minutes after the
method of choice had been applied, the surgical incision
was performed and the surgical procedure commenced.
Recordings
Preoperative, intraoperative, and postoperative data
on oxygen saturation, heart rate (ECG, lead II) and
non-invasive arterial pressure (oscillometry) were record-
ed automatically every 5 minutes or less if required by an
anaesthetic monitor machine.
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To assess cardiovascular responses to the applied spe-
cific measures for the control of bleeding, heart rate (HR)
and non-invasive arterial pressure measurements (sys-
tolic (SBP), diastolic (DBP) and mean blood pressure
(MAP)) were recorded prior to the applied measure (base-
line values), immediately after the applied measure (val-
ues at 0 minutes), and 5 and 10 minutes after the applied
measure. Haemodynamic changes >20% were consid-
ered as clinically not acceptable. All recorded data were
printed at the end of surgery.
To assess visibility of the surgical field a 6-point scale
was used (5), where 0= no bleeding; 1= slight bleeding,
blood evacuation not necessary; 2= slight bleeding,
some blood must be evacuated; 3= low bleeding, blood
must be evacuated frequently as the operative field is vis-
ible only briefly after evacuation; 4= average bleeding,
blood must be evacuated often as the operative field is
visible only immediately after evacuation, and 5=high
bleeding, constant blood evacuation needed, as often
bleeding exceeds evacuation, rendering surgery nearly
impossible. An anaesthesiologist rated the score.
To assess the intraoperative need for systemic analge-
sics, intraoperative fentanyl consumption was recorded
in mg on the anaesthetic chart by an anaesthesiologist.
Intraoperative midazolam and vecuronium consump-
tion was also recorded.
The occurrence of intraoperative adverse events dur-
ing the applied measures, including hypotension (de-
crease in SBP from 30% of baseline), hypertension (in-
crease in SBP from 30% of baseline), tachycardia (HR of
>100 beat per minute) and bradycardia (HR of <50 beat
per minute) were also recorded.
Statistical analysis
Categorical data were expressed as frequencies, and
presented as numbers or percentage. Distribution of nu-
merical data was determined with the Kolmogorov-Smir-
nov test and Shapiro Wilk tests of normality. Normally
distributed data were expressed as mean±standard devia-
tion (SD), whereas not normally distributed data were
presented as median with interquartile range (IQR). Data
on gender and complications were compared by c2 test.
Age, weight, height, ASA, duration of surgery and anaes-
thesia, intraoperative drug consumption, and fluid ad-
ministration were compared by Kruskal-Wallis test. One-
-way ANOVA test followed by Scheffe’s post-hoc test was
used for differences in SBP, DBP, MAP and HR between
groups. Paired t test was used for intragroup differences
in SBP, DBP, MAP and HR. Bleeding scores were as-
sessed by Kruskal Wallis and Wilcoxon signed ranks test.
P < 0.05 was considered statistically significant. Statisti-
cal analysis was performed with SPSS software for Win-
dows, version 11.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
There was no difference between the groups regard-
ing age (p=0.570), body mass index (p=0.425), gender
(p=0.264), ASA (p=0.862), duration of surgery (p=0.134),
duration of anaesthesia (p=0.108), intraoperative con-
sumption of fentanyl (p=0.460) (Table 1). Intraoperative
midazolam (p= 0.336) and vecuronium (p=0.300) con-
sumption, and intraoperative fluid administration (p=
0.095) were the same in all three groups.
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TABLE 1
Demographic and intraoperative data.













Gender (male/female) 10/8 13/12 21/8
ASA (I/II) 10/8 12/13 14/15






Duration of general anaesthesia (min) 60 (55–77) 50 (40–60) 60 (47.5–60)






Data are presented as medians with ±(25%/75% interquartile range) (not normal data distribution) or numbers (categorica data).
There was no significant difference between the groups.
BMI = body mass index
ASA = American Society of Anaesthesiologists score
LA-E = lidocaine/adrenaline infiltration plus ephedrine pledgets
LA = lidocaine/adrenaline infiltration
E = ephedrine pledgets
Table 2 shows mean (±SD) changes in heart rate
(HR) bmin-1, and mean arterial pressure (MAP) mmHg
as measured at four time points.
There was no difference in baseline HR and MAP be-
tween the groups nor at 0 minutes.
HR at 5 minutes was significantly lower in LA group
compared to E-group (by 15%, mean difference –15.91,
SE 4.169, p=0.012) and compared to LA-E group (by
15%, mean difference –11.57, SE 4.427, p=0.039). HR
at 10 minutes was 18% lower in LA group (mean differ-
ence –14.89, SE 4.279, p=0.004) compared to E group
(Table 2).
MAP at 5 minutes was significantly by 16 % lower in
LA group (mean difference –15.91, SE 4.169, p<0.001)
compared to E group. MAP at 10 minutes was by 12%
lower in LA-E group (mean difference –14.95, SE 5.383,
p=0.026) and by 23% LA group (mean difference –
25.57, SE 4.896, p<0.001) compared to E group.
When compared within LA-E group, MAP showed a
statistical significant decrease immediate after infiltra-
tion compared to baseline (by 9% p=0.044). There was a
statistical significant increase in MAP at 5 minutes com-
pared to values at 0 minutes (by 8%, p=0.037). At 10
minutes MAP were statistically higher only when com-
pared to the values at 0 minutes (by 12%, p=0.037), but
not to baseline or immediate previous measurement at 5
minutes (Table 2).
Within LA group, there was a significant decrease in
HR at 0 minutes, 5 minutes and 10 minutes when com-
pared to baseline (by 7 %, p=0.005; by 11%, p<0.001; by
11%, p=0.001, respectively). HR at 5 minutes was by 5 %
lower compared to HR at 0 minutes (p=0.029) (Table 2).
Within E group, HR was similar in all measured
points, except that the value at 10 minutes was slightly
higher compared to 5 minutes (by 4 %, p=0.052). MAP
within E group was higher at 5 minutes and 10 minutes
compared to baseline (by 6 %, p=0.025; by 15%, p<0.001,
respectively). MAP at 5 minutes and 10 minutes was
higher than the value at 0 minutes (by 7%, p=0.007; by
16% p<0.001, respectively). MAP at 10 minutes was by
11% higher than that at 5 minutes (p<0.001) (Table 2).
The most frequent grading scores for the bleeding in
the surgical filed were Score 2 (n=26, 36.1%) and Score 3
(n=25, 34.7%). There was a significant difference in the
bleeding rating score between the groups (p<0.001). Av-
erage bleeding score was 2.28±0.83 (median 2.00 IQR
2-3) in LA-E, 2.08±0.81 (median 2.00 IQR 1.5-3) in LA
and 3.14±0.74 (median 3.00 IQR 3-4) in E group.
Majority of patients (n=47, 65.3 %) had no complica-
tions. Hypertension was registered as the most often
complication (40%). There was no difference between
the groups (p= 0.133).
DISCUSSION
In this study we compared three different pre-treat-
ments of nasal mucosa used by our otorhynolaryngolo-
gists during nasal surgery under general anaesthesia: lo-
cal infiltration of 2% lidocaine with adrenaline; cotton
pledgets soaked with 1% ephedrine, or the combination
of ephedrine topical application and lidocaine infiltra-
tion on nasal mucosa.
Our results showed greatest haemodynamic stability
in the group with local infiltration of lidocaine with
adrenaline compared to groups with ephedrine alone or
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TABLE 2
Mean (±SD) changes in heart rate (HR) bmin-1 and mean arterial pressure (MAP) mmHg in group LA-E (n=18), group LA
(n=25) and group E (n=29), observations: baseline; immediate after application (0 min); 5 min after application; 10 min after
application.
Group Baseline 0 min 5 min 10 min
HR
bmin-1
LA-E 80.94 ± 15.17 79.94 ± 16.13 79.17 ± 17.64 78.44 ± 18.30
LA 76.16 ± 14.18 70.80 ± 10.65a 67.6 ± 11.66†,‡,b, d 67.80 ± 11.34†, c
E 81.62 ± 12.56 79.48 ± 14.50 79.59 ± 14.15 82.69 ± 17.09f
MAP
mmHg
LA-E 94.17 ± 9.76 85.44 ± 17.44a 92.39 ± 16.64d 97.22 ± 19.44*,e
LA 86.60 ± 12.04 90.56 ± 19.69 84.92 ± 16.21† 86.60 ± 19.84†
E 94.86 ± 13.64 93.83 ± 12.94 100.83 ± 13.47b,d 112.17 ± 15.05c,e,f
*significant difference LA-E vs E <0.05; †significant difference LA vs E <0.05, ‡significant difference LA vs LA-E <0.05
a – significant difference 0 min vs baseline <0.05 within the same group; b – significant difference 5 min vs baseline <0.05 within the
same group; c – significant difference 10 min vs baseline <0.05 within the same group; d – significant difference 5 min vs 0 min <0.05
within the same group; e – significant difference 10 min vs 0 min <0.05 within the same group; f – significant difference 10 min vs 5min
<0.05 within the same group
LA-E = lidocaine/adrenaline infiltration plus ephedrine pledgets
LE = lidocaine/adrenaline infiltration
E = ephedrine pledgets
the combination of lidocaine infiltration with the topical
ephedrine application. In the group with infiltration of
lidocaine with adrenaline, there was only difference in
HR during the study period, which was less than 10%,
and that is clinically insignificant and acceptable. On the
contrary, the ephedrine did not influence HR but caused
an increase in blood pressure with maximum of 17%.
This increase falls within a clinically acceptable range of
less than 20%; however, when compared to LA- group
this difference was 23%, which is clinically not accept-
able. LA-E group demonstrated in a certain way the
characteristics of both groups. In comparison to LA
group, it had more oscillations in blood pressures, but
compared to ephedrine group these were clinically ac-
ceptable. This lead us to conclude that infiltration of
lidocaine with adrenaline has a beneficial and counter-
acting effect to ephedrine on systemic haemodynamics
when used in combination.
The incidence of haemodynamic complications was a
secondary end point of this study. Unfortunately, because
of the size number, we did not determine any statistically
significant difference. However, we found important,
from the clinical point of view, more hypertensive cases
in the ephedrine group, and two hypotensive cases asso-
ciated with the infiltration of lidocaine with adrenaline.
Ephedrine reaction is easily explained by its pharmaco-
logical effect on a1- and a2-adrenergic receptors (6).
However, there is a certain lack of clarity regarding the
mechanism of the hypotensive reaction of lidocaine with
adrenaline. Enlund et al. showed lidocaine-induced dose-
-depended arterial hypotension when combined with a
defined level of general anaesthesia during orthognathic
surgery (7). On the contrary, Yang et al., in their later per-
formed study, related the registered hypotensive reaction
to adrenaline only (8). Enlund reanalysed both studies
and found significant differences in the extent of the
hypotensive reaction in Yang's and his study, and found
also difference in the doses of lidocaine and adrenaline
used (9). As an integrative conclusion, it was stated that a
combination of relatively small doses of lidocaine (ap-
proximately 40 mg) and adrenaline results in profound
hypotension, mainly as a result of the adrenergic b2 ef-
fect. In addition, a combination of relatively large doses
of lidocaine and adrenaline results in less severe hypo-
tension, as a result of predominately affected b1 receptors
(9). This explanation also seems appropriate for under-
standing of haemodynamic manifestations related to li-
docaine with adrenaline in our study. Our doses of lido-
caine and adrenaline, and the extent of haemodynamic
oscillations were more similar to the study of Enlund et
al. We did not demonstrate profound hypertension, ex-
cept in the noted cases, although we also demonstrated
the tendency of lidocaine to lower the values of blood
pressure.
In addition, it helps to explain the best average bleed-
ing score demonstrated in lidocaine with adrenaline group
compared to ephedrine. Obviously, to achieve the best
surgical conditions, it is necessary to control systemic and
local haemodynamics simultaneously. Ephedrine may be a
good decongestant, but in our study showed undesirable
increases in blood pressure. Therefore, it is not surpris-
ing that the addition of ephedrine or topical application
of ephedrine alone resulted in worse bleeding scores in
our study.
When compared to other techniques for decreasing
bleeding in the nasal operative field with the same bleed-
ing score scale, our results were satisfying. Boezaart et al.
achieved 2.94±0.34 by using a hypotensive technique
with esmolol (5). Our best score achieved with infiltra-
tion of lidocaine with adrenaline was 2.08±0.81. In a re-
cent study, Ayoglu et al. achieved, however, 1.7±1.2 by us-
ing dexmedetomidine in septoplasty under general
anaesthesia (10).
Our study has a few limitations that should be ad-
dressed before the final conclusion. The main limitation
of our study is its open design without randomisation
and masking. The surgeon decided on patient allocation
according to his preference. However, to avoid their bias,
an anaesthesiologist did the scoring. Masking in our
study could not have been in any case achievable because
the application of ephedrine and lidocaine are two differ-
ent techniques that could not be blinded. The possible
advantage of the study was that we had a good pool of pa-
tients with systematically collected data, so we were able
to carry out a strict selection and finally obtain compara-
ble groups of patients. Therefore, although the study de-
sign was made retrospectively, we believe we obtained
useful results. The study period was focused and limited
on a relatively short period, so haemodynamic values
were related to the studied measures exclusively, exclud-
ing any other potential influence of applied treatments
such as deepening/lightening anaesthesia, fluid over-
loading, drug application etc.
In conclusion, we demonstrated that the local infiltra-
tion of lidocaine with adrenaline showed statistically and
clinically significantly more desirable haemodynamic pro-
perties and achieved better visibility of the surgical field
when compared to topical ephedrine application in pa-
tients undergoing septoplasty under general anaesthesia.
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